Skip to main content
. 2015 Nov 25;310(3):R286–R296. doi: 10.1152/ajpregu.00469.2014

Table 3.

Vascular sensitivity reported as logEC50 to phenylephrine in aortic preparations from SS.13BN rats and Dahl SS rats with or without PVAT or ENDO in the presence or absence of NOS inhibition with l-NAME

Aortic Preparation SS-13BN Dahl SS
LogEC50 (M) Determined From the % Increase in Force to Phenylephrine
−PVAT+ENDO −7.06 ± 0.08 −7.55 ± 0.19*
+PVAT+ENDO −5.97 ± 0.30 −6.09 ± 0.14
+PVAT-ENDO −7.62 ± 0.21§ −8.21 ± 0.17*§
−PVAT-ENDO −8.01 ± 0.16 −8.31 ± 0.14*
+PVAT+ENDO+l-NAME −7.13 ± 0.19§ −7.79±.025§
−PVAT+ENDO+l-NAME −7.83 ± 0.13 −7.79 ± 0.09

Values are expressed as means ± SE.

*

P < 0.05 vs. respective SS.13BN aortic preparation;

P < 0.05 vs. −PVAT+ENDO within same rat strain;

§

P < 0.05 vs. +PVAT+ENDO within same rat strain.

For SS.13BN rats, n = 8–10. For Dahl SS rats, n = 5–9.